122 related articles for article (PubMed ID: 2165822)
21. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase by Triton X-100.
Sharma RK; Wang JH
Biochem Biophys Res Commun; 1981 May; 100(2):710-5. PubMed ID: 6268071
[No Abstract] [Full Text] [Related]
22. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
Suh-Kim H; Wei X; Birnbaumer L
Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365
[TBL] [Abstract][Full Text] [Related]
23. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
[TBL] [Abstract][Full Text] [Related]
24. Calmodulin, Ca2+-antagonists and Ca2+-transporters in nerve and muscle.
Johnson JD; Wittenauer LA; Nathan RD
J Neural Transm Suppl; 1983; 18():97-111. PubMed ID: 6308155
[TBL] [Abstract][Full Text] [Related]
25. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
[TBL] [Abstract][Full Text] [Related]
26. An endogenous Ca2+-dependent activator protein of brain adenylate cyclase and cyclic neucleotide phosphodiesterase.
Cheung WY; Lynch TJ; Wallace RW
Adv Cyclic Nucleotide Res; 1978; 9():233-51. PubMed ID: 208377
[No Abstract] [Full Text] [Related]
27. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of NZ-105, a 1,4-dihydropyridine derivative, on cyclic nucleotide phosphodiesterase activity.
Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
J Pharm Pharmacol; 1993 Jun; 45(6):530-4. PubMed ID: 7689649
[TBL] [Abstract][Full Text] [Related]
29. Purification and characterization of bovine lung calmodulin-dependent cyclic nucleotide phosphodiesterase. An enzyme containing calmodulin as a subunit.
Sharma RK; Wang JH
J Biol Chem; 1986 Oct; 261(30):14160-6. PubMed ID: 3021730
[TBL] [Abstract][Full Text] [Related]
30. Interactions of calmodulin antagonists with calcium antagonists binding sites.
Schaeffer P; Lugnier C; Stoclet JC
Eur J Pharmacol; 1991 Apr; 206(4):325-32. PubMed ID: 1655490
[TBL] [Abstract][Full Text] [Related]
31. Increased cyclic nucleotide phosphodiesterase (PDE) and calmodulin activities in soluble fraction of Graves' thyroid: analysis of increase in Ca+2 dependence of PDE activities.
Yagura T; Nagata I; Kuma K; Uchino H
J Clin Endocrinol Metab; 1985 Jun; 60(6):1180-6. PubMed ID: 2987288
[TBL] [Abstract][Full Text] [Related]
32. Preparation of an enzymatically active cross-linked complex between brain cyclic nucleotide phosphodiesterase and 3-(2-pyridyldithio)propionyl-substituted calmodulin.
Kincaid RL
Biochemistry; 1984 Mar; 23(6):1143-7. PubMed ID: 6324862
[TBL] [Abstract][Full Text] [Related]
33. Calmodulin interacts with cyclic nucleotide phosphodiesterase and calcineurin by binding to a metal ion-independent hydrophobic region on these proteins.
Gopalakrishna R; Anderson WB
J Biol Chem; 1983 Feb; 258(4):2405-9. PubMed ID: 6296146
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation by casein kinase II alters the biological activity of calmodulin.
Sacks DB; Davis HW; Williams JP; Sheehan EL; Garcia JG; McDonald JM
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):21-4. PubMed ID: 1314563
[TBL] [Abstract][Full Text] [Related]
35. Different sensitivities of Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterases from rabbit aorta and brain to dihydropyridine calcium channel blockers.
Matsushima S; Tanaka T; Saitoh M; Watanabe M; Hidaka H
Biochem Biophys Res Commun; 1987 Nov; 148(3):1468-74. PubMed ID: 2825687
[TBL] [Abstract][Full Text] [Related]
36. Heat-stable calmodulin-binding protein in rat testis. Inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase activity.
Ono T; Koide Y; Arai Y; Yamashita K
J Biol Chem; 1984 Jul; 259(14):9011-6. PubMed ID: 6086620
[TBL] [Abstract][Full Text] [Related]
37. Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I.
Kincaid RL; Vaughan M; Osborne JC; Tkachuk VA
J Biol Chem; 1982 Sep; 257(18):10638-43. PubMed ID: 6286665
[No Abstract] [Full Text] [Related]
38. Topographical mapping of calmodulin-target enzyme interaction domains.
Mann DM; Vanaman TC
J Biol Chem; 1989 Feb; 264(4):2373-8. PubMed ID: 2536706
[TBL] [Abstract][Full Text] [Related]
39. KS-501 and KS-502, new inhibitors of Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Sporothrix sp.
Nakanishi S; Ando K; Kawamoto I; Kase H
J Antibiot (Tokyo); 1989 Jul; 42(7):1049-55. PubMed ID: 2546910
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence investigations of calmodulin hydrophobic sites.
Follenius A; Gerard D
Biochem Biophys Res Commun; 1984 Mar; 119(3):1154-60. PubMed ID: 6324780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
